As sales from the 340B Drug Pricing Program reach $100 billion, the Trump administration, Congress and pharmaceutical companies are moving quickly to modify the program and reduce flexibilities.
Total costs of prescription drugs purchased under the 340B discount drug program increased 22.8% year-over-year, according to new data from...National News
A coalition of over 130 hospitals has filed suit against the U.S. Department of Health and Human Services over methodology used to calculate risk payments to hospitals that treat a higher number of Medicare patients.
As it stands now, the Centers for Medicare and Medicaid Services estimates the number of low-income patients served by...CMS Rules
The FY 2024 Hospital Inpatient Prospective Payment System (IPPS) and Long-term Care Hospital Prospective Payment System (LTCH PPS) rule was finalized by the Centers for Medicare and Medicaid Services (CMS) on August 1 and contains a shocking projected cut to disproportionate share hospitals (DSH).
For all hospitals, the rule provides...
The American Hospital Association (AHA) ran a survey of 300 hospitals and health systems to determine the overall impact of cuts made to the 340B prescription drug pricing program. It found an enormous financial impact on struggling hospitals, specifically those in rural and underserved areas.
The 340B drug pricing program requires...
In addition to overturning Roe v. Wade and with it abortion access for millions of American women, the Supreme Court ended their term this year with a slew of other decisions that will carry new precedent for health industry legal cases going forward.
Last Friday, the high court announced an end to a years-long fight between the U.S....
